>> 全站文章索引 >> 第6页:
  • Contrast sensitivity and magnocellular functioning in schizophrenia - [Bernt C.Skottun a,John R.Skoyles b,c,*]
  • Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia - [Yuanrong Yao,Johannes Schroder,Ha˚kan Karlsson]
  • The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia - [F.-A.Wiesel,L.Bjerkenstedt,G.Edman,L.Flyckt]
  • Delayed sympathetic hyperactivity is induced by ECT in patients with schizophrenia - [Tatsuro Kuwahara,Aihide Yoshino,Soichiro Nomura]
  • Childhood adversities and psychosocial disorders - [Maughan B, McCarthy G.]
  • Changes in Cognitive Functioning Following Treatment of Late-Life Depression - [Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, Reynolds CF 3rd]
  • Association between youth-focused firearm laws and youth suicides - [Webster DW, Vernick JS, Zeoli AM, Manganello JA]
  • Antidepressants and Pediatric Depression The Risk of Doing Nothing - [Brent DA]
  • Antidepressant Prescribing Practices of Outpatient Psychiatrists - [Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA.]
  • Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia： A randomized, open-label, controlled trial - [Sung-Wan Kim a,b,Il-Seon Shin a,b,Jae-Min Kim a,b,Seung-Hyun Lee c]
  • The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia - [Michael S.Ritsner a,b,Vladimir Yorkov a,Yael Ratner a,Peter Soifer a,Anatoly Gibel a]
  • Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care - [Yael Ratner a,Anatoly Gibel a,Vladimir Yorkova,Michael S.Ritsnera,b]
  • Increased cerebellar vermis white-matter volume in men with schizophrenia - [Kwang-Hyuk Lee a,*,Tom F.D.Farrow a,Randolph W.Parks a,Lisa D.Newton a]
  • Psychiatric syndromes comorbid with mental retardation： Differences in cognitive and adaptive skills - [Santo F.Di Nuovoa,*,Serafino Buono b]
  • Disturbed frontal gyrification within families affected with schizophrenia - [Peter Falkaia,*,William G.Honer b,Thomas Kamer j,Simone Dustert]
  • Self-assessment of functional status in schizophrenia - [Christopher R.Bowie*,Elizabeth W.Twamley,Hannah Anderson,Brooke Halpern,Thomas L.Patterson,Philip D.]
  • Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics - [Xiang Yang Zhanga,Yun Long Tan,Dong Feng Zhou,Lian Yuan Cao,Gui Ying Wu,Qi Xu,Yan Shen,Colin N.Haile]
  • A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10 - [Joseph P.McEvoya,David G.Daniel b,William H.Carson Jr.c,Robert D.McQuade c,Ronald N.Marcusd]
  • Antidepressant pharmacotherapy in the treatment of depression in the very old： a randomized placebo-controlled trial - [Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H; O]
  • Antidepressant drug therapy and suicide in severely depressed children and adults - [Olfson M, Marcus SC, Shaffer D]
  • Aging and clinical pharmacology: implications for antidepressants - [Lotrich FE, Pollock BG]
  • Age effects on antidepressant-induced manic conversion - [Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D.]
  • A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder - [.]
  • Psychological debriefing for preventing post traumatic stress disorder (PTSD) - [S Rose, J Bisson, R Churchill, S Wessely]
  • Atypical antipsychotics for people with both schizophrenia and depression - [VA Furtado, V Srihari]
  • Impaired working memory monitoring in euthymic bipolar patients - [Jill M Thompson, John M Gray, John H Hughes, Stuart Watson, Allan H Young, I Nicol Ferrier]
  • Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis - [I. J. Torres1,2,3,4, V. G. Boudreau1,4, L. N. Yatham4]
  • Symptoms of Anxiety and Depression in the Course of Cognitive Decline - [E.J.M. Bierman, H.C. Comijs, C. Jonker, A.T.F. Beekman]
  • Is it time to reassess the BDNF hypothesis of depression - [J O. Groves1, JO Groves]
  • Mixed Depression and the Dimensional View of Mood Disorders - [Franco Benazzi]
  • Patients perspectives on what works in psychoeducational groups for schizophrenia：A qualitative study - [Ingrid Sibitz1, 2, Michaela Amering1, Ralf Gössler2, Annemarie Unger1 and Heinz Katschnig1]
  • IIncremental validity of anxiety sensitivity in terms of motivation to quit reasons for quitting - [Michael J. Zvolensky ; Anka A. Vujanovic ; Marcel O. Bonn Miller ; Amit Bernstein ; Andrew R. Yartz]
  • Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia - [Hao-Yang Tan, Joseph H. Callicott and Daniel R. Weinberger]
  • Web-based communications and management of a multi-center clinical trial - [Wisniewski SR, Eng H, Meloro L, Gatt R, Ritz L, Stegman D, Trivedi M, Biggs MM, Friedman E, Shores-W]
  • Treatment Matching in the Posthospital Care of Depressed Patients - [Miller IW, Keitner GI, Ryan CE, Solomon DA, Cardemil EV, Beevers CG]
  • Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants a meta-analysis - [Anderson IM, Tomenson BM]
  • The Endophenotype Concept in Psychiatry Etymology and Strategic Intentions - [Gottesman II, Gould TD.]
  • Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials - [Khan A, Warner HA, Brown WA]
  • Schizophrenia as a Complex Trait - [Patrick F.Sullivan,MD,FRANZCP;Kenneth S.Kendler,MD;Michael C.Neale,PhD]
  • Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression - [Frank E, Kupfer DJ, Buysse DJ, Swartz HA, Pilkonis PA, Houck PR, Rucci P, Novick DM, Grochocinski VJ]
  • Randomised controlled trials investigating pharmacological and psychological - [Stimpson N, Agrawal N, Lewis G]
  • Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy - [Hochstrasser B, Isaksen PM, Koponen H, Lauritzen L, Mahnert FA, Rouillon F, Wade AG, Andersen M, Ped]
  • Primary care physicians' approach to depressive disorders. Effects of physician specialty and practice structure - [Williams JW Jr, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J]
  • Prevention of relapse following cognitive therapy vs medications in moderate to severe depression - [Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O]
  • Preventing recurrent depression using cognitive therapy with and without a continuation phase - [Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC.]
  • Predictors of relapse in a prospective study of fluoxetine treatment of major depression - [McGrath PJ, Stewart JW, Quitkin FM, Chen Y, Alpert JE, Nierenberg AA, Fava M, Cheng J, Petkova E]
  • Poor P50 suppression among schizophrenia patients and their first-degree biological relatives - [Clementz BA, Geyer MA, Braff DL]
  • Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression - [Reynolds CF 3rd, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Sta]
  • Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia - [Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC]
  • National trends in the outpatient treatment of depression - [Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA]
  • Multiple dimensions of schizotypy in first degree biological relatives of schizophrenia patients - [Calkins ME, Curtis CE, Grove WM, Iacono WG]
  • Longitudinal course of pediatric bipolar disorder - [Birmaher B]
  • Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders - [Jindal RD, Thase ME.]
  • Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression - [Frank E, Shear MK, Rucci P, Cyranowski JM, Endicott J, Fagiolini A, Grochocinski VJ, Houck P, Kupfer]
  • Hippocampal volumes in schizophrenic twins - [van Erp TG, Saleh PA, Huttunen M, Lönnqvist J, Kaprio J, Salonen O, Valanne L, Poutanen VP, Standert]
  • Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures - [Gur RE, Kohler CG, Ragland JD, Siegel SJ, Lesko K, Bilker WB, Gur RC]
  • Evaluation of outcomes with citalopram for depression using measurement-based care - [Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowit]
  • Endophenotyping Schizophrenia - [Braff D, Schork NJ, Gottesman II]
  • Depression treatment preferences in older primary care patients - [Gum AM, Areán PA, Hunkeler E, Tang L, Katon W, Hitchcock P, Steffens DC, Dickens J, Unützer J]
  • Deconstructing Schizophrenia:An Overview of the Use of Endophenotypes in Order to Understand a Complex Disorder - [Braff DL, Freedman R, Schork NJ, Gottesman II.]
  • Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression - [DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O]
  • Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments:a STAR*D report - [Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrat]
  • Cognitive Therapy and Interpersonal Psychotherapy 30 Years Later - [Weissman MM.]
  • Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project - [Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Key T, Biggs MM, Shores-Wilson K]
  • Chronic depression:medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not - [Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, K]
  • Can Psychiatry Cross the Quality Chasm? Improving the Quality of Health Care For Mental and Substance Use Conditions - [Pincus HA, Page AE, Druss B, Appelbaum PS, Gottlieb G, England MJ]
  • Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression - [Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D]
  • Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride - [Martin SD, Martin E, Rai SS, Richardson MA, Royall R]
  • An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Depressed Inpatients - [Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger M.]
  • Inroads to Mechanisms of Disease in Child Psychiatric Disorders - [Kates WR.]
  • Predictors of symptomatic remission in people with schizophrenia identified - [Dr Roger S Mcintyre1 and Joanna K Soczynska, Hbsc2]
  • Psychotherapy for dental anxiety - [P McGoldrick, A de Jongh, R Durham, J Bannister, J Levitt]
  • Intermittent drug techniques for schizophrenia - [M Mansour, A Alomar, K Boobes, MA Mouchli]
  • Pathophysiology of early onset schizophrenia - [Marinos Kyriakopoulos ; Sophia Frangou]
  • Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old - [Mona Mehta, Ellen Whyte, Eric Lenze, Susan Hardy, Yazan Roumani, Perera Subashan, Wennie Huang, Step]
  • Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype - [C M. Middeldorp1 2, J-J. Hottenga1, P E. Slagboom3, P F. Sullivan4, E J C. de Geus1, D. Posthuma1, G]
  • Evaluation of an Online Relapse Prevention Program for Bipolar Disorder: An Overview of the Aims and Methodology of a Randomized Controlled Trial - [Caryl Barnes 1; Robin Harvey 2; Philip Mitchell 1; Michael Smith2; Kay Wilhelm1]
  • Mapping Callosal Morphology in Early- and Late-Onset Elderly Depression: An Index of Distinct Changes in Cortical Connectivity - [Martina. Ballmaier1 2 3, Anand. Kumar4, Virginia. Elderkin-Thompson4, Katherine L. Narr2, Eileen. Lu]
  • Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study - [Kaan Yucel1, Margaret C. McKinnon1, Valerie H. Taylor1, Kathryn Macdonald1, Martin Alda2, L. Trevor]
  • The Sounds of Silence: Language, Cognition, and Anxiety in Selective Mutism - [Manassis, Katharina M.D.; Tannock, Rosemary Ph.D.; Garland, E.Jane M.D.; Minde, Klaus M.D.; McInnes,]
  • Acceptability of second-step treatments to depressed outpatients: a STAR*D report - [Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim H]
  • A Double-blind, Randomized, Placebo-Controlled Trial of Pindolol Augmentation in Depressive Patients Resistant to Serotonin Reuptake Inhibitors - [Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.]
  • Inroads to Mechanisms of Disease in Child Psychiatric Disorders - [Wendy R. Kates]
  • A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression - [Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Rus]
  • Phenomenology of children and adolescents with bipolar spectrum disorders - [Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyenga]
  • One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype - [Geller B, Craney JL, Bolhofner K, DelBello MP, Williams M, Zimerman B]
  • Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype - [Geller B, Tillman R, Craney JL, Bolhofner K.]
  • Clinical Course of Children and Adolescents With Bipolar Spectrum Disorders - [Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyenga]
  • 伴躁狂症状的双相抑郁患者辅助使用抗抑郁剂治疗及恢复：STEP-BD研究的结果 - [Joseph F. Goldberg, M.D., Roy H. Perlis, M.D., S. Nassir Ghaemi, M.D]
  • 非ANOVA分析 - [Ralitza Gueorguieva, PhD; John H. Krystal, MD]
  • 一个敏感性强的新抑郁量表 - [SA Montgomery and M Asberg]
  • Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression - [C-L Dennis, K Giavedoni]
  • One extra month of depression: the effects of caregiving on depression outcomes in the IMPACT trial - [Alex Thompson, Ming-Yu Fan, Jürgen Unützer, Wayne Katon]
  • Ethnicity/Race and Outcome in the Treatment of Depression: Results From STAR*D - [Lesser, Ira M.Md*; Castro, Daniel B.Md†; Gaynes, Bradley N.Md]
  • Associations between symptoms of attention deficit hyperactivity disorder, depression, and suicide in Korean female adolescents - [Soo-Churl Cho, M.D, Jae-Won Kim, M.D, Hyun-Jung Choi, M.A., Boong-Nyun Kim, M.D]
  • Effect of Comorbid Anxiety Disorders on the Hypothalamic-Pituitary-AdrenalAxis Response to a Social Stressorin Major Depression - [E. Young, J. Abelson, O. Cameron]
  • Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists - [Weisberg RB, Dyck I, Culpepper L, Keller MB]
  • A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety Disorders - [Hettema JM, Neale MC, Kendler KS]
  • Neurobiological Mechanisms of Social Anxiety Disorder - [Mathew SJ, Coplan JD, Gorman JM]
  • Depressed Adolescents Grown Up - [Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, Greenwald S, Klier CM, Ryan ND, Dahl RE, Wickr]


    • 分页: 1 2 3 4 5 [6] 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50